Trial reportRevista do Colegio Brasileiro de Cirurgioes2025
A comparative cost analysis study of pulmonary robotic and video-assisted lobectomy: results of a randomized controlled trial (BRAVO Study).
Trial report in Revista do Colegio Brasileiro de Cirurgioes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Clinical research advances in thoracic surgery and thoracic oncology in 2025: a panoramic narrative review.Journal of thoracic disease · 2026Review
- Financial sustainability and the incorporation of technologies in the Brazilian Unified Health System: advances, challenges, and perspectives.Sao Paulo medical journal = Revista paulista de medicina · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionRobotic thoracic surgery has potential benefits, but the cost is still considered a limiting factor for its wide dissemination in most countries.
methodsWe compared the costs of robotic-assisted (RATS) and video-assisted thoracic surgery (VATS) in the treatment of lung cancer or pulmonary metastasis. Cost analysis was based on micro-costing and individual cost analysis during surgical admission and frequency of services (emergency service, clinic visits, imaging exams, chemotherapy and radiotherapy, reoperation or additional procedures, rehospitalization, and ICU stay) during postoperative 90-day follow-up.
resultsA total of 76 patients were included in this cost analysis (RATS=37, VATS=39). Groups were equivalent in terms of age, gender, comorbidities, and pre-operative status. Total costs of pulmonary lobectomy did not differ between the RATS and VATS groups when considering cost of surgical hospitalization and follow-up of up to 90 days. Mean individual cost per patient in the RATS group was R$35,590.41 (±12,514.97) and R$41,066.98 (±25,891.04) in the VATS group, p=0.564.
conclusionRobotic and video-assisted thoracic surgery had similar costs, but longer follow-up studies could be important to demonstrate RATS and VATS costs differences.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.